Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,245.6
-37.7 (-1.15%)

 

  • STI Straits Times Index
    3,245.6
    -37.7 (-1.15%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,505.3
    -16.5 (-1.09%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,357.1
    -299.3 (-1.21%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,484.8
    -39.3 (-1.12%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 533.4M
  • Value: 668.2M
  • Rise: 46
  • Fall: 215
  • Unch: 506

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
DISA0.008-
Jiutian Chemical0.086+0.001
Stamford Land R0.003-
YZJ Shipbldg SGD1.280-0.040
Sembcorp Marine0.082-0.001
Singtel2.450-0.040
Shen Yao0.003-
Genting Sing0.735-0.025
HS Optimus0.004-
ThaiBev0.650-0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,855.1 +86.2
HSI 24,345.0 -311.5
HSCEI 8,567.8 -90.3
Jakarta 6,554.4 -100.8
Nikkei 225 27,588.4 +66.1
SSE Comp 3,484.8 -39.3
Shanghai A 3,651.9 -41.2
Shanghai B 282.2 -3.0
KOSPI 2,711.9 -80.1

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 25 Jan 2022 12:00
Last (SGD): 0.300 Change: -0.005 High: 0.305 Remarks: -
Change (%): -1.64 Low: 0.295
Open 0.305 Yesterday's Close 0.305
Buy Price 0.300 Sell Price 0.300
Buy Volume ('000) 103.4 Sell Volume ('000) 1.3
Cumulative Volume ('000) 2,242.2 Cumulative Value 675,462
Free Trial
 

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.31869 Trailing EPS (SGD) b 0.26644 NAV (SGD) c 0.4594
PE a 0.941 Trailing PE d 1.126 Price / NAV c 0.6530
Dividend Yield (%) e 22.491 Cash In Hand (SGD) f 0.1504 Issued & Paid-up Shares g 546,411,000
Piotroski F Score 8 Market Cap (M) 163.923 Free Float (%) 99.4
Return on Equity (ROE) (%) h 57.995 Revenue Growth (%) TTM i 52.006
Net Earnings Growth (%) j 163.617 Net Debt/Equity k Net Cash
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 24 Aug 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.025
-7.69 %
10 Days --0.070
-18.92 %
20 Days --0.035
-10.45 %
Medium Term Return 3 Months --0.080
-21.05 %
6 Months --0.510
-62.96 %
1 Year 0.056-0.840
-68.77 %
Long Term Return 2 Years 0.067+0.196
+252.88 %
3 Years 0.067+0.271
+1165.52 %
5 Years 0.067+0.253
+680.85 %
Annualised Return Annualised --
+50.84 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.
Free Trial

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 163.923 0.941 1.126 0.6530 22.491
Industry Medical & Biotechnology SGX 1,024.954 18.940 15.583 1.4319 1.915
Medical Specialties SGX 961.792 2.045 2.793 2.5112 27.020
Index FTSE ST Catalist Index SGX 60.057 26.056 20.548 1.3629 2.104
Local Peer Top Glove SGX 5,204.618 2.045 2.852 2.8660 29.190
Local Peer UGHealthcare SGX 168.433 1.418 1.418 0.8835 1.870
Local Peer Yunnan Energy SGX 46.549 - - 1.4359 -
Local Peer Biolidics SGX 44.596 - - 8.4422 -
Local Peer Annica SGX 16.675 - - 10.0000 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 226,892.838 35.591 26.491 5.8613 0.154
Global Peer ABBOTT LABORATORIES NYSE 218,949.668 48.949 30.359 6.3607 1.238
Global Peer DANAHER CORP NYSE 197,837.788 56.364 34.575 4.9234 0.259
Global Peer MEDTRONIC PLC NYSE 140,116.598 38.856 29.780 2.6950 2.228
Global Peer INTUITIVE SURGICAL INC NASDAQ 97,089.245 - - - -
Global Peer STRYKER CORP NYSE 95,034.301 59.434 50.018 6.7029 0.932
Global Peer BECTON DICKINSON & CO NYSE 74,099.778 37.013 37.013 3.1299 1.275
Global Peer EDWARDS LIFESCIENCES CORP NYSE 69,051.340 83.861 46.742 12.4613 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 60,790.073 - 58.340 3.6927 -
Global Peer BAXTER INTERNATIONAL INC NYSE 43,039.570 39.056 35.453 4.9076 1.120
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), NOVOCURE LTD (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), GLOBUS MED INC (NYSE), SHANGHAI MICROPORT MEDBOT (GROUP) C (HKEx), MICROPORT SCIENTIFIC CORPORATION (HKEx), SOTERA HEALTH CO (NASDAQ), SHANDONG WEIGAO GROUP MEDICAL (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), STEVANATO GROUP S.P.A. (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), EBOS GROUP (ASX), HARTA (Bursa), ANGELALIGN TECHNOLOGY INC (HKEx), QUIDEL CORP (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), LIVANOVA PLC (NASDAQ), TOPGLOV (Bursa), IRHYTHM TECHNOLOGIES INC (NASDAQ), NEOGEN CORP (NASDAQ), CONMED CORP (NYSE), INARI MEDICAL INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), INMODE LTD (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NEVRO CORP (NYSE), NUVASIVE INC (NASDAQ), ATRICURE INC (NASDAQ), LUMIRADX LTD (NASDAQ), HAEMONETICS CORP (NYSE), GLAUKOS CORPORATION (NYSE), AXONICS INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), CAREDX INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), OUTSET MEDICAL INC (NASDAQ), VENUS MEDTECH (HANGZHOU) INC (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), HESKA CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), VERICEL CORP (NASDAQ), AVANOS MEDICAL INC (NYSE), KANGJI MEDICAL HLDGS LTD (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), CUE HEALTH INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), NANOSONICS LIMITED (ASX), ATRION CORP (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), PARAGON 28 INC (NYSE), BIOVENTUS INC (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), PEIJIA MEDICAL LIMITED (HKEx), ALPHATEC HLDGS INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), TREACE MED CONCEPTS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), CERUS CORP (NASDAQ), PULMONX CORPORATION (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), ANGIODYNAMICS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SUPERMX (Bursa), VIEWRAY INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), AIRSCULPT TECHNOLOGIES INC (NASDAQ), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), SIGHT SCIENCES INC (NASDAQ), INOGEN INC (NASDAQ), SI BONE INC (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), INTERCURE LTD (NASDAQ), VICARIOUS SURGICAL INC (NYSE), CUTERA INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), NANO-X IMAGING LTD (NASDAQ), SISRAM MEDICAL LTD (HKEx), NYXOAH SA (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), IRADIMED CORP (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), INCANNEX HEALTHCARE LTD (ASX), 908 DEVICES INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), TRANSMEDICS GROUP INC (NASDAQ), VAPOTHERM INC (NYSE), STEREOTAXIS INC (NYSE American), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), ACCURAY INCORPORATED (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), DERMTECH INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), AXOGEN INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZYNEX INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), SHANGHAI CONANT OPTICAL CO LTD (HKEx), AROA BIOSURGERY LTD (ASX), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), MEDICAL DEVELOPMENT INTL (ASX), NEUROPACE INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), IMPEDIMED LIMITED (ASX), CLEARPOINT NEURO INC (NASDAQ), PROFOUND MED CORP (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), QUOTIENT LTD (NASDAQ), LUCIRA HEALTH INC (NASDAQ), EARGO INC (NASDAQ), CVRX INC (NASDAQ), SONENDO INC (NYSE), TELA BIO INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CORMEDIX INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), SIENTRA INC (NASDAQ), ONCOCYTE CORP (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), MINERVA SURGICAL INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), CONFORMIS INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), PAVMED INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), INTRICOM CORP (NASDAQ), SOMNOMED LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), CYCLOPHARM LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), ELECTROMED INC (NYSE American), ENLIVEX THERAPEUTICS LTD (NASDAQ), FONAR CORP (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), NEURONETICS INC (NASDAQ), INVACARE CORP (NYSE), RGTBHD (Bursa), ATOMO DIAGNOSTICS LIMITED (ASX), ICECURE MEDICAL LTD (NASDAQ), VENUS CONCEPT INC (NASDAQ), MICRO-X LTD (ASX), SDI LTD (ASX), IRIDEX CORP (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), CLEANSPACE HOLDINGS LTD (ASX), VOLITIONRX LIMITED (NYSE American), ALPHA PRO TECH (NYSE American), IMMUCELL CORP (NASDAQ), OPTISCAN IMAGING (ASX), REWALK ROBOTICS LTD (NASDAQ), KELFRED HOLDINGS LTD (HKEx), LENSAR INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), INTEGRITY APPLICATIONS INCORPORATIO (NASDAQ), DIMERIX LTD (ASX), RESONANCE HEALTH LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOMERICA INC (NASDAQ), ENVVENO MED CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BIOLASE INC (NASDAQ), CHECK-CAP LTD (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), NEPHROS INC (NASDAQ), COMPUMEDICS (ASX), DELCATH SYSTEMS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), CARDIEX LTD (ASX), MEDAVAIL HOLDINGS INC (NASDAQ), DAXOR CORP (NYSE American), ELECTROCORE INC (NASDAQ), BLUEJAY DIAGNOSTICS INC (NASDAQ), YUNNAN ENERGY INTL CO LTD (HKEx), NUTRIBAND INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ADVENTA (Bursa), NEUROMETRIX INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), NEOVASC INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), RESPIRI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), AVINGER INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), AETHLON MEDICAL INC (NASDAQ), TIVIC HEALTH SYSTEMS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), APPLIED UV INC (NASDAQ), INSPIREMD INC (NASDAQ), ADHERIUM LIMITED (ASX), RESHAPE LIFESCIENCES INC (NASDAQ), HEARTBEAM INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), TRUSCREEN GROUP LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), CYANOTECH CORP (NASDAQ), LKL (Bursa), TENAX THERAPEUTICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), USCOM LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), METALICITY LIMITED (ASX), OVENTUS MEDICAL LTD (ASX), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), SINTX TECHNOLOGIES INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), RA MEDICAL SYSTEMS INC (NYSE American), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.